Issue No 01+02/2005

Clin. Lab. 2005;51:1-4 Abstract REVIEW ARTICLE

What Cardiologists do Need to Know about Procalcitonin

by Christian Mueller, Mirjam Christ-Crain, Beat Müller
Clin. Lab. 2005;51:5-9 Abstract REVIEW ARTICLE

The Use of B-type Natriuretic Peptide in the Diagnosis of Acute Dyspnoea

by Christian Mueller, Kirsten Laule-Kilian, Andreas Christ, Daniel Staub
Clin. Lab. 2005;51:11-19 Abstract ORIGINAL ARTICLE

Serum Hyaluronic Acid Levels are Elevated in Arthritis Patients, but Normal and Not Associated with Clinical Data in Patients with Fibromyalgia Syndrome

by Egon Werle, Hans-Peter Jäkel, Annette Müller, Heinrich Fischer, Walter Fiehn, Wolfgang Eich
Clin. Lab. 2005;51:21-29 Abstract REVIEW ARTICLE

Evolution of the Parathyroid Hormone (PTH) Assay - Importance of Circulating PTH Immunoheterogeneity and of its Regulation

by Ping Gao and Pierre D'Amour
Clin. Lab. 2005;51:31-41 Abstract ORIGINAL ARTICLE

The Abbott Architect c8000: Analytical Performance and Productivity Characteristics of a New Analyzer Applied to General Chemistry Testing

by Daniela Pauli, Michael Seyfarth, and Leif Dibbelt
Clin. Lab. 2005;51:43-45 Abstract ORIGINAL ARTICLE

Clinical Significance of Hematocrit Interference in the Tacrolimus II Microparticle Enzyme Immunoassay: A Tentative Approach

by Jesús Hermida, M. Concepción Fernández, J. Carlos Tutor
Clin. Lab. 2005;51:47-48 Abstract LETTER TO THE EDITOR

Sealing Ability of a Glass Ampoule

by Yutaka Tajima
Clin. Lab. 2005;51:49-53 Abstract ORIGINAL ARTICLE

Evaluation of Alkaline Phosphatase Activity Assay for the Reflotron® System after Substitution of the Comparison Method

by Ulrich Hübner, Gerhard Pape, Johannes Lotz, Thomas Bertsch, Manfred Kraft, Jürgen Geisel, and Wolfgang Herrmann
Clin. Lab. 2005;51:63-72 Abstract REVIEW ARTICLE

Rationale for Testing the Cardiovascular Risk for Patients with COX-2 Inhibitors on the Basis of Biomarker NT-proBNP

by Evangelos Giannitsis
Clin. Lab. 2005;51:73-83 Abstract REVIEW ARTICLE

Rationale zur Testung des kardiovaskulären Risikos bei Patienten mit COX-2-Hemmern anhand des Biomarkers NT-proBNP

by Evangelos Giannitsis